Based on the news about the stock in the past five trading days, please predict the rise or fall of the stock in the next trading day. If the stock is predicted to rise in the next trading day, please output [Rise], if the stock is predicted to fall in the next trading day, please output [Decrease].

Date:2019-06-10, Stock:PFE, The news for the past five days is as follows:
2019-06-03: NEWS1: 6 High-Yield Stocks.NEWS2: Comparing Pfizer’s and Merck’s Vaccines Businesses.NEWS3: How Is Pfizer’s Biopharmaceuticals Group Positioned in 2019?.NEWS4: How Losses of Exclusivity Are Playing Out for PFE and MRK in 2019.NEWS5: Merck's Keytruda Improves 5-Year Survival in Lung Cancer.NEWS6: Merck's Keytruda Improves 5-Year Survival in Lung Cancer.NEWS7: Blueprint Medicines' NDA for Avapritinib on Track for GIST.NEWS8: Blueprint Medicines' NDA for Avapritinib on Track for GIST.NEWS9: Comparing Pfizer’s and Merck’s 2019 Revenue Growth Trajectories.NEWS10: What Analysts Are Expecting from Pfizer and Merck in June.NEWS11: XLV, EGPT: Big ETF Outflows.NEWS12: XLV, EGPT: Big ETF Outflows.NEWS13: Blueprint Medicines' NDA for Avapritinib on Track for GIST.NEWS14: Merck's Keytruda Improves 5-Year Survival in Lung Cancer.NEWS15: Phibro Animal Health Corporation (PAHC) Ex-Dividend Date Scheduled for June 04, 2019.NEWS16: Phibro Animal Health Corporation (PAHC) Ex-Dividend Date Scheduled for June 04, 2019.NEWS17: Matinas BioPharma to Present at the 9th Annual LD Micro Invitational.
2019-06-04: NEWS1: Top Research Reports for Pfizer, Coca-Cola & VMware.NEWS2: Top Research Reports for Pfizer, Coca-Cola & VMware.NEWS3: Top Research Reports for Pfizer, Coca-Cola & VMware.NEWS4: See what the IHS Markit Score report has to say about Pfizer Inc..NEWS5: Ultimate Stock-Pickers' Top 10 Buys and Sells.
2019-06-05: NEWS1: Blueprint Medicines to File NDA for Avapritinib With FDA.NEWS2: Blueprint Medicines to File NDA for Avapritinib With FDA.NEWS3: Jeff Settleman, Ph.D., Joins Pfizer to Lead Oncology Research & Development.NEWS4: Top Tips for Long-Term Stock Investors.NEWS5: Top Tips for Long-Term Stock Investors.NEWS6: How Merck reached new ground in the fight against cancer.NEWS7: Blueprint Medicines to File NDA for Avapritinib With FDA.NEWS8: The Zacks Analyst Blog Highlights: Pfizer, Coca-Cola, VMware, NIKE and AIG.NEWS9: The Zacks Analyst Blog Highlights: Pfizer, Coca-Cola, VMware, NIKE and AIG.NEWS10: Top Tips for Long-Term Stock Investors.NEWS11: The Zacks Analyst Blog Highlights: Pfizer, Coca-Cola, VMware, NIKE and AIG.NEWS12: Health Care Sector Update for 06/05/2019: RWLK, IFRX, SRRA, JNJ, PFE, ABT, MRK, AMGN.NEWS13: Health Care Sector Update for 06/05/2019: RWLK, IFRX, SRRA, JNJ, PFE, ABT, MRK, AMGN.NEWS14: Pfizer to Launch Several Drugs Despite Generic Headwinds.NEWS15: 10 Jaw-Dropping Numbers About Cancer Drug Development -- and What They Mean for Investors.
2019-06-06: NEWS1: Pfizer (PFE) Outpaces Stock Market Gains: What You Should Know.NEWS2: Zacks Market Edge Highlights: Pfizer, Vanguard S&P 500 ETF, Global X Social Media ETF, Kraneshares China Internet ETF and Microsoft.NEWS3: Zacks Market Edge Highlights: Pfizer, Vanguard S&P 500 ETF, Global X Social Media ETF, Kraneshares China Internet ETF and Microsoft.NEWS4: Lilly's Emgality Gets FDA Approval for Cluster Headache.NEWS5: Lilly's Emgality Gets FDA Approval for Cluster Headache.NEWS6: 5 Reasons Pfizer Sat on a Potential New Alzheimer's Drug.NEWS7: 5 Reasons Pfizer Sat on a Potential New Alzheimer's Drug.NEWS8: Health Care Sector Update for 06/06/2019: MTFB, PLX, SEEL, JNJ, PFE, ABT, MRK, AMGN.NEWS9: Health Care Sector Update for 06/06/2019: MTFB, PLX, SEEL, JNJ, PFE, ABT, MRK, AMGN.NEWS10: Lilly's Emgality Gets FDA Approval for Cluster Headache.NEWS11: Zacks Market Edge Highlights: Pfizer, Vanguard S&P 500 ETF, Global X Social Media ETF, Kraneshares China Internet ETF and Microsoft.NEWS12: 3 Big Stock Charts for Thursday: Pfizer, Walmart and FleetCor Technologies.
2019-06-07: NEWS1: Health Care Sector Update for 06/07/2019: LJPC, TXMD, GSK, JNJ, PFE, ABT, MRK, AMGN.NEWS2: Health Care Sector Update for 06/07/2019: LJPC, TXMD, GSK, JNJ, PFE, ABT, MRK, AMGN.NEWS3: Why I'm Sticking With My 3 Worst-Performing Stocks of 2019 So Far.NEWS4: Why I'm Sticking With My 3 Worst-Performing Stocks of 2019 So Far.NEWS5: Why I&apos;m Sticking With My 3 Worst-Performing Stocks of 2019 So Far.NEWS6: Germany's Stada buys six of GSK's consumer brands, eyes further deals.

Answer: Rise